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The EMBO Journal REFEREE REPORTS Referee #1
In this paper, the authors report that VhaPRR, which the authors and others have previously linked to the V-ATPase, interacts with the protocadherin Fmi through its extracellular domain and colocalizes with PCP proteins during all pupal wing stages. They also report that this localization depends on intact PCP domains, and vice-versa, suggesting that VhaPRR is itself a PCP core protein. Finally, they report that VhaPRR also plays a role in acidification and endosomal transport, and conclude that VhaPRR is a key factor in epithelial morphogenesis.
I find the paper potentially interesting and I have only a few comments on the possible role of VhaPRR in acidification and traffic -it seems to me that this role remains somewhat obscure. It is remarkable that, except acidic vesicles, all markers related to endo-lysosomes that have been tested are increased in the VhaPRR mutant cells (Lamp1, Armadillo, Notch, endocytosed E-cad), including Rab5, Rab 11 and Rab7. This may support the view that VhaPRR mutant cells exhibit an acidification defect, as proposed by the authors. However, beyond the difference in the distribution of apical vesicles, the lysotracker staining intensity of individual vesicles whether wt/mutant or apical/basal looks very similar (Fig 6) . This argues against a defect in the acidification properties, at least at the level of lysotracker detection. Do Rab proteins also accumulate in V-ATPase mutants? Also, is the pH of endo-lysosomes or Lamp1 degradation affected after Fmi or Fz disruption? Also, in VhaPRR mutant clones, there is little difference in the basal lysotracker staining, but the number of apical vesicles stained with the dye is reduced. Is the cell shape changed in the mutant? This is not easy to see in the x-y projection in Fig 6D, because nuclei are not in the focal plane of mutant cells. Is the number of endosomes and lysosomes reduced in the apical portion of the cell? Conversely, do authors know whether the basal, Lamp1-positive vesicles, which accumulate in the mutant, are acidic?
Referee #2
The Hermle et al manuscript has 2 parts. The first one is an extension of the characterization of the role VhaPRR in the regulation of PCP (Hermel et al., 2010 , Buechling et al., 2010 and Cruciat et al., 2010 . The novel findings include 1) VhaPRR affects the trafficking of Fmi; 2) VhaPRR is planar polarized; 3) VhaPRR can form a complex with Fmi. In a second part the authors analyse the role of VhaPRR in vesicular trafficking. They show that the loss of VhaPRR function perturbs vesicle acidification as well as Notch and E-Cadherin trafficking. Although the authors' findings suggest a role of VhaPRR in Fmi trafficking, the connection between the function of VhaPRR in vesicular trafficking and its role in PCP is not explored. It also remains unclear why the loss of function of VhaPRR drastically perturbs Stbm and Fz localizations, while it only mildly affects Fmi localization. Furthermore, the following points should be addressed: 1. The loss of VhaPRR drastically affects Fz and Stbm localization, whereas it has a milder effect on the one of Fmi. Is the trafficking of Fz and/or Stbm also affected by the loss of VhaPRR function? Do Fmi, Fz or Stbm colocalize in intercellular (intracellular?) structures? 2. Upon Fmi antibody incubation at 4{degree sign}C, the amount of Fmi is lower at the apical AJs. The authors therefore need to quantify the reduction of Fmi membrane localization upon chase at 25{degree sign}C to demonstrate that there is indeed a stronger reduction of Fmi at VhaPRR apical junction. A better characterization of the dynamics of Fmi internalization might be relevant (see Strutt 2011). 3. The authors state that VhaPRR is localized both at the distal and proximal cell junction. However, VhaPRR is absent from many proximal or distal junctions facing the mutant clones in figure 2D . A far better experiment would be to use a GFP::VhaPRR construct to demonstrate that VhaPRR localizes both at the distal and proximal junctions. 4. In figure 7B , it is unclear how the antibody can access the extracellular E-Cad in the absence of detergent since a cuticle is likely present on the apical side of the wing pupal cells at 32APF. 5. It is unclear how the role of VhaPRR in lysosomal degradation might lead to an accumulation of E-Cad at the apical cell junction. Could the authors demonstrate that the increase in E-cadherin is indeed due to more recycling to the apical domain? Point-by-point response:
Referee #1
We thank the reviewers for their helpful comments and suggestions for the improvement of our manuscript. We respond to the criticisms and suggestions in italicized text below:
I find the paper potentially interesting and I have only a few comments on the possible role of VhaPRR in acidification and traffic -it seems to me that this role remains somewhat obscure. It is remarkable that, except acidic vesicles, all markers related to endo-lysosomes that have been tested are increased in the VhaPRR mutant cells (Lamp1, Armadillo, Notch, endocytosed E-cad), including Rab5, Rab 11 and Rab7. This may support the view that VhaPRR mutant cells exhibit an acidification defect, as proposed by the authors. However, beyond the difference in the distribution of apical vesicles, the lysotracker staining intensity of individual vesicles whether wt/mutant or apical/basal looks very similar (Fig 6) . This argues against a defect in the acidification properties, at least at the level of lysotracker detection. Figure 8 and Supplementary Figure S7 . They are also summarized in the schematic model of Figure 9 . We find that Figure 8J and Supplementary Figure S7D) . Figure S7G) Also, in VhaPRR mutant clones, there is little difference in the basal lysotracker staining, but the number of apical vesicles stained with the dye is reduced. Is the cell shape changed in the mutant? This is not easy to see in the x-y projection in Fig 6D, because nuclei are not in the focal plane of mutant cells. Is the number of endosomes and lysosomes reduced in the apical portion of the cell? Conversely, do authors know whether the basal, Lamp1-positive vesicles, which accumulate in the mutant, are acidic? Figure  6 with a proper x-z projection (as opposed to wing margin cells; inset in Figure 6B ') that show normal nuclear organization inside the clones. We also included co-labeling with E-Cadherin to show outlines of cells accumulating LAMP1 (Figure 6E'' Figure 6 as panel F and G).
We are happy to see that reviewer #1 finds our paper interesting. We have now more precisely addressed the role of VhaPRR in acidification and traffic, including a detailed comparison of VhaPRR clones with clones mutant for another V-ATPase, Vha68-2, and clones mutant for PCP proteins. These new results can be found in

LAMP1 degradation was assessed by expressing Fmi RNAi with dpp-GAL4 in a tub-GFP-LAMP1 background (Supplementary
As GFP-LAMP1 accumulates in vesicular compartments in apical and basal parts of the cell and Rab proteins, particularly Rab11, localizes to apical compartments, we do not think that there is a general reduction of apical compartments. In some clones there is a slight misorganization of the epithelium, which may be due to compromised cell viability. We have replaced the images in
specific defect in acidification of apical compartments (now in included in
Referee #2
The Hermle et al manuscript has 2 parts. The first one is an extension of the characterization of the role VhaPRR in the regulation of PCP (Hermle et al., 2010 , Buechling et al., 2010 and Cruciat et al., 2010 . The novel findings include 1) VhaPRR affects the trafficking of Fmi; 2) VhaPRR is planar polarized; 3) VhaPRR can form a complex with Fmi. In a second part the authors analyse the role of VhaPRR in vesicular trafficking. They show that the loss of VhaPRR function perturbs vesicle acidification as well as Notch and E-Cadherin trafficking. Although the authors' findings suggest a role of VhaPRR in Fmi trafficking, the connection between the function of VhaPRR in vesicular trafficking and its role in PCP is not explored. Figure  S4B) Figure 8 and Supplementary Figure 7 . They are also summarized in the schematic model of Figure 9 .
We have now significantly expanded our studies on the connection of the trafficking function of VhaPRR and its role in PCP. An important milestone was the successful generation of somewhat viable V-ATPase loss-of-function clones in the pupal wing using the Vha68-2 allele and an altered heat-shock protocol (Vaccari et al, 2010). As stated in the first version of the manuscript and in Hermle et al, 2010, this has proved difficult in the past due to cytotoxic effects caused by impaired V-ATPase activity. Mutant clones or RNAi expression domains are mostly viable only for a short time before they are eliminated. In Vha68-2 clones we observed similar trafficking defects as in VhaPRR clones (Lysotracker reduction, Rab protein increase, E-Cadherin increase), but PCP protein localization and wing hair orientation is mostly unaffected. To compare the localization of the V-ATPase with VhaPRR, we have also used a Vha55-GFP trap line. Vha55-GFP can be used to assess endogenous Vha55 localization (and function), because we demonstrate that the GFP signal can be eliminated by expression of Vha55 RNAi (Figure 8I). As with other tools we have used (Vha44 antibody (
not V-ATPase dependent) and one in trafficking (not Fmi-dependent, VATPase dependent). Most of the new data is presented in
It also remains unclear why the loss of function of VhaPRR drastically perturbs Stbm and Fz localizations, while it only mildly affects Fmi localization.
See Point 1.
Furthermore, the following points should be addressed: Figure 1I ).
3. The authors state that VhaPRR is localized both at the distal and proximal cell junction. However, VhaPRR is absent from many proximal or distal junctions facing the mutant clones in figure 2D . A far better experiment would be to use a GFP::VhaPRR construct to demonstrate that VhaPRR localizes both at the distal and proximal junctions. Figure S3C, Figure 1B and Supplementary Figure S1C) .
As we have shown in Supplementary
In figure 7B , it is unclear how the antibody can access the extracellular E-Cad in the absence of detergent since a cuticle is likely present on the apical side of the wing pupal cells at 32APF.
A cuticle is indeed present at this stage of pupal wing development. However, during dissection we physically remove it, so it does not prevent antibody binding to E-Cadherin on the cell surface. This can only be done with fixed samples. Therefore, the antibody uptake assay is not possible at this stage.
4. It is unclear how the role of VhaPRR in lysosomal degradation might lead to an accumulation of E-Cad at the apical cell junction. Could the authors demonstrate that the increase in E-cadherin is indeed due to more recycling to the apical domain?
In our antibody uptake assay, we see an increase in intracellular E-Cadherin upon chasing with the antibody, so endocytic uptake does not seem to be affected. However, at the same time there is an enhanced signal at the apical junctions. Therefore, enhanced recycling is to us the most likely explanation. E-Cadherin has been shown to recycle via the Rab11-dependent pathway in Drosophila epithelial cells (Langevin et al, 2005 Figure S5) . We also detected a strong increase of Rab11 staining in apical compartment upon VhaPRR elimination, which may reflect an activated recycling pathway. A positive correlation between junctional E-Cadherin and apical Rab11 is supported by our Vha68-2 experiments ( Figure 8R and Supplementary Figure S7A) 
